All Stories

  1. Targeting the endothelin system: a step towards a precision medicine approach in heart failure with preserved ejection fraction?

    Article • European Heart Journal, November 2019, Oxford University Press (OUP)

    Professor Torbjorn Omland

  2. Cardiac imaging and circulating biomarkers for primary prevention in the era of precision medicine

    Article • Expert Review of Precision Medicine and Drug Development, September 2019, Taylor & Francis

    Professor Torbjorn Omland

  3. Aiming toWards Evidence baSed inTerpretation of Cardiac biOmarkers in patients pResenting with chest pain-the WESTCOR study: study design

    Article • Scandinavian Cardiovascular Journal, July 2019, Taylor & Francis

    Rune Bjørneklett, Professor Torbjorn Omland, Paul Collinson

  4. Temporal Changes in Cardiac Troponin I Are Associated with Risk of Cardiovascular Events in the General Population: The Nord-Trøndelag Health Study

    Article • Clinical Chemistry, April 2019, AACC

    Professor Torbjorn Omland

  5. Novel biomarkers of cardiovascular disease: Applications in clinical practice

    Article • Critical Reviews in Clinical Laboratory Sciences, November 2018, Taylor & Francis

    Professor Torbjorn Omland

  6. Cardiac Troponin T Increase in Patients with Acute Ischemic Stroke with and without Cancer

    Article • Clinical Chemistry, November 2017, AACC

    Professor Torbjorn Omland

  7. Effect of candesartan and metoprolol on myocardial tissue composition during anthracycline treatment: the PRADA trial

    Article • European Heart Journal - Cardiovascular Imaging, June 2017, Oxford University Press (OUP)

    Professor Torbjorn Omland

  8. State of the Art: Blood Biomarkers for Risk Stratification in Patients with Stable Ischemic Heart Disease

    Article • Clinical Chemistry, November 2016, AACC

    Professor Torbjorn Omland

  9. Prognostic Value of Secretoneurin in Patients with Acute Respiratory Failure: Data from the FINNALI Study

    Article • Clinical Chemistry, August 2016, AACC

    Professor Torbjorn Omland

  10. Prevention of cardiac dysfunction during adjuvant breast cancer therapy (PRADA): a 2 × 2 factorial, randomized, placebo-controlled, double-blind clinical trial of candesartan and metoprolol

    Article • European Heart Journal, February 2016, European Society of Cardiology

    Professor Torbjorn Omland

  11. Effect of weight loss on subclinical myocardial injury: A clinical trial comparing gastric bypass surgery and intensive lifestyle intervention

    Article • European Journal of Preventive Cardiology, December 2015, SAGE Publications

    Professor Torbjorn Omland

  12. Influence of Glycosylation on Diagnostic and Prognostic Accuracy of N-Terminal Pro-B-Type Natriuretic Peptide in Acute Dyspnea: Data from the Akershus Cardiac Examination 2 Study

    Article • Clinical Chemistry, June 2015, AACC

    Professor Torbjorn Omland

  13. Impact of Sex on the Prognostic Value of High-Sensitivity Cardiac Troponin I in the General Population: The HUNT Study

    Article • Clinical Chemistry, February 2015, AACC

    Professor Torbjorn Omland

  14. Standardized evaluation of lung congestion during COPD exacerbation better identifies patients at risk of dying

    Article • International Journal of Chronic Obstructive Pulmonary Disease, December 2013, Taylor & Francis

    Professor Torbjorn Omland